Pre-Open Movers: Snap Down on Results, Lack of Guidance; Hospitals Tenet, HCA Jump Jul 22, 2022 09:11AM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Stronghold, Aurinia, and Lilium and Encourages Investors to Contact the Firm Jun 8, 2022 09:00PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Stronghold, Aurinia, and Lilium and Encourages Investors to Contact the Firm May 23, 2022 09:00PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Twitter, Aurinia, Stronghold, and Lilium and Encourages Investors to Contact the Firm May 18, 2022 09:00PM
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm May 8, 2022 09:00PM


May 2, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm
Dec 9, 2021 06:15AM Aurinia Pharmaceuticals (AUPH) Reports Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS
Dec 9, 2021 06:15AM Aurinia Announces Positive Topline Results From the AURORA 2 Continuation Study of LUPKYNIS™ (voclosporin) for the Treatment of Adults With Active Lupus Nephritis (LN)
Dec 15, 2020 05:59PM Aurinia and Lonza Announce Exclusive Agreement for Dedicated Voclosporin Manufacturing Capacity
Sep 4, 2019 06:42AM Companies with NDRs 09/04
May 10, 2019 07:00AM Aurinia Recognizes World Lupus Day and Lupus Awareness Month with Activities Focused on Raising Awareness for Lupus Nephritis
Mar 14, 2019 07:00AM Aurinia Recognizes World Kidney Day and National Kidney Month with New Activities Focused on Raising Awareness for Kidney Disease
Oct 12, 2017 07:00AM Aurinia Receives National Corporate Visionary Award from the Lupus Foundation of America
Apr 17, 2017 04:04PM Aurinia Pharmaceuticals (AUPH) Announces Licensing Deal for Nanomicellar Formulation of Voclosporin with Merck Animal Health
Apr 17, 2017 04:02PM Aurinia Completes Licensing Deal with Merck Animal Health for Its Nanomicellar Formulation of Voclosporin for the Treatment of Canine Dry Eye Syndrome
Oct 6, 2016 12:57PM Unusual 11 Mid-Day Movers 10/6: (GNK) (AUPH) (GTWN) Higher; (ALNY) (INVT) (TWTR) Lower